Iwicki Mark T 4
4 · KALA BIO, Inc. · Filed Oct 24, 2025
Insider Transaction Report
Form 4
KALA BIO, Inc.KALA
Iwicki Mark T
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Sale
Common Stock
2025-10-23$0.81/sh−154,894$125,464→ 103,540 total
Footnotes (2)
- [F1]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.78 to $0.85, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
- [F2]Includes 103,540 unvested RSUs.